Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune disease with genetic roots, and treatments include specific topical therapies.

PUVA treatment led to significant hair regrowth in over half of the patients with alopecia areata totalis and universalis.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Trichoscopy is useful for diagnosing different types of hair loss.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Calcipotriol cream can effectively and safely treat mild-to-moderate patchy hair loss.

Higher BMI links to worse hair loss in Taiwanese men.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Early-onset alopecia, especially with a family history, leads to worse outcomes and more related health issues.

Alopecia areata is a common autoimmune disease affecting hair follicles, with unclear causes and a need for better treatments.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Indinavir can cause hair loss and other skin problems.

Men over 35 with hair improvement felt better psychologically, while younger men felt better even without hair improvement.

Keeping radiation doses under 16 Gy may reduce permanent hair loss.

A unique gene mutation causes vitamin D-resistant rickets without causing hair loss.

Turner's syndrome may be linked to autoimmune diseases like psoriasis and alopecia areata, needing comprehensive care.

Some psychotropic medications can rarely cause hair loss, and stopping these drugs usually reverses the condition.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Ruxolitinib can help regrow hair in severe alopecia areata.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Black and Hispanic women are more likely to have alopecia areata than white women.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

A woman with severe hair loss was successfully treated with the drug adalimumab.